glp-1 agonists oral Frontiers Peptidyl and Non-Peptidyl Oral Glucagon-Like
Description
No heart attacks, strokes, or cardiovascular deaths have been attributed to retatrutide in published trial data
An overview of GLP1 agonists and recent cardiovascular outcomes trials
Side Effects Comparison Since both medications affect gut hormones and slow gastric emptying, they cause similar side effects
Ahlin S, Peltonen M, Sjholm K, Anveden, Jacobson P, Andersson-Assarsson JC, et al
